Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Text Messaging Follow-up From ED

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03370978
Recruitment Status : Not yet recruiting
First Posted : December 13, 2017
Last Update Posted : January 11, 2019
Sponsor:
Information provided by (Responsible Party):
Brooks Obr, University of Iowa

Brief Summary:
Ensuring follow-up for patients after discharge from the emergency department (ED) has long been a concern for ED care providers. The current technology of text messaging may be able to assist us in improving follow-up rates. In addition, having a quick and easy communication tool to be in touch with providers may improve overall patient satisfaction. This study is designed to evaluate the usage of text messaging to improve follow-up appointment compliance from the Emergency Department. In this study, a prospective randomized controlled trial (RCT) will be performed (involving patients scheduled by Emergency Department Nurse Navigators to follow up with Family Medicine) in which patients will be randomized to a texting appointment reminder versus standard-of-care (no texting reminder) group. Texted patients will receive reminders 3 days and 1 day prior to their follow-up appointment. In addition, the patients will have the ability to text back-and-forth with the Nurse Navigators in order to ask questions/request clarification if needed. Chart review will be performed of both groups to evaluate the number of follow-up appointments that patients attended versus rescheduled versus did not attend/reschedule. These values will then be compared to the retrospective chart review previously performed to evaluate for non-inferiority of text messaging as a means of improving patient attendance at follow-up appointments.

Condition or disease Intervention/treatment Phase
Text Messaging Behavioral: Text Messaging Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 624 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Other
Official Title: The Role of Text Messaging in Follow-up Appointments for Patients Discharged From the Emergency Department
Estimated Study Start Date : March 1, 2019
Estimated Primary Completion Date : December 1, 2019
Estimated Study Completion Date : December 31, 2020

Arm Intervention/treatment
Experimental: Text Messaging
Receives text messages to remind of upcoming follow-up appointment with primary care doctor. Also provides opportunity for subjects to text ED staff for follow-up care concerns or to reschedule primary care appointment.
Behavioral: Text Messaging

To communicate with intervention patients after discharge from the ED, we will use a bidirectional text messaging service provided by another physician's research group within the University of Iowa. The nurse navigator will enter the patient's study identification number, first and last name and cell phone onto a secure study website established by this research group.

Patients will, as previously mentioned, have had their cell phone number tested in the text messaging system prior to leaving the Emergency Department (this includes the control group).

Patient's will receive a text message 3 days, and 1 day, prior to their scheduled follow-up appointment with Family Medicine (this appointment having been scheduled through the Emergency Department Nurse Navigators). Each text message will remind the patient of the date/time of their appointment, and provide them a link containing a map with the location of their appointment.


No Intervention: Usual Care
Received usual care including follow-up phone calls if clinically indicated.



Primary Outcome Measures :
  1. Attending Primary Care Appointment [ Time Frame: Less than 6 months ]
    Attending appointment versus rescheduling versus not showing



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. At least 18 years old
  2. Able to read, write and communicate in English - English as the primary language
  3. Has a phone with capabilities for text messaging
  4. Identifies oneself as someone who is comfortable with text messaging.
  5. To follow-up with Family Medicine as outpatient (Scheduled through Emergency Department Nurse Navigators).
  6. Evaluated in the University of Iowa Hospitals and Clinics Emergency Department

Exclusion Criteria:

  1. Absence of one or more inclusion criteria
  2. Not able to provide informed consent or participate due to limited decision-making ability.
  3. Prisoner
  4. Previously has followed with the University of Iowa Hospitals and Clinics Family Medicine (i.e., would not be a "new" patient establishing care).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03370978


Contacts
Layout table for location contacts
Contact: Brooks Obr, MD 319-353-6360 brooks-obr@uiowa.edu
Contact: Karisa Harland, PhD kari-harland@uiowa.edu

Locations
Layout table for location information
United States, Iowa
University of Iowa Hospitals and Clinics Not yet recruiting
Iowa City, Iowa, United States, 52242
Contact: Brooks Obr, MD    319-353-6360      
Sponsors and Collaborators
University of Iowa

Layout table for additonal information
Responsible Party: Brooks Obr, Principal Investigator, University of Iowa
ClinicalTrials.gov Identifier: NCT03370978     History of Changes
Other Study ID Numbers: 201607734
First Posted: December 13, 2017    Key Record Dates
Last Update Posted: January 11, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No IPD will be shared

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No